53Biologics ha sido distinguida hoy con el Premio Pyme del Año 2025 de Valladolid, un reconocimiento otorgado por Banco Santander y la Cámara de Comercio de Valladolid, en colaboración con la Cáma...
Read moreAgnes Arbat stresses that the program promoted by ICEX has been a transforming experience both professionally and strategically. As she explains, it allowed her to gain in-depth knowledge of the U.S. ...
Read moreThis article explores the scope of preclinical contract research, best practices in study design, key FDA toxicology guidelines for compliance, and common challenges that impact project efficiency.
Read moreMELINA is one of the projects supported by this funding, and it aims to develop and harness the full potential of artificial intelligence (AI) tools, and more specifically machine learning (ML), for t...
Read moreA consortium formed by the Clínica Universidad de Navarra, the Hospital Universitario de Navarra, the University of Navarra, the research centers FIMA and Navarrabiomed, and the technology companies ...
Read moreA public-private consortium led by the biotechnology company Nuage Therapeutics has initiated the development of an innovative therapy against the most frequent subtype of small cell lung cancer (SCLC...
Read moreEn su tesis doctoral realizada en IQS, el Dr. Endika Torres ha desarrollado y aplicado diferentes modelos de predicción para la generación de inhibidores duales contra las proteínas quinasa FGFR2 e...
Read more100% Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients
Read moreThe transition of a synthetic peptide from research to commercialization requires robust analytical method development and validation, particularly the establishment of highly specific, stability-indi...
Read moreBiopharmaceutical company Oniria Therapeutics, Vall d’Hebron Institute of Oncology (VHIO) and Institut Català d’Investigació Química (ICIQ) will work together on the regulatory preclinical phas...
Read moreLa Fundación MEDINA inicia una nueva fase de crecimiento científico con el lanzamiento de una plataforma avanzada de modelos celulares de enfermedades humanas, reforzando así sus capacidades en el ...
Read moreEn este artículo echamos un vistazo a las novedades sobre el fármaco lecanemab, el primero aprobado por la vía tradicional por algunas agencias reguladoras del medicamento tras décadas de la últi...
Read more